These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

555 related articles for article (PubMed ID: 18822343)

  • 1. The role of bone in phosphate metabolism.
    Fukumoto S
    Mol Cell Endocrinol; 2009 Oct; 310(1-2):63-70. PubMed ID: 18822343
    [TBL] [Abstract][Full Text] [Related]  

  • 2. FGF23 is a hormone-regulating phosphate metabolism--unique biological characteristics of FGF23.
    Fukumoto S; Yamashita T
    Bone; 2007 May; 40(5):1190-5. PubMed ID: 17276744
    [TBL] [Abstract][Full Text] [Related]  

  • 3. FGF23 and Bone and Mineral Metabolism.
    Fukumoto S
    Handb Exp Pharmacol; 2020; 262():281-308. PubMed ID: 31792685
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Disorders of phosphate metabolism].
    Fukumoto S
    Rinsho Byori; 2010 Mar; 58(3):225-31. PubMed ID: 20408440
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Klotho gene, phosphocalcic metabolism, and survival in dialysis.
    Torres PU; Prié D; Beck L; De Brauwere D; Leroy C; Friedlander G
    J Ren Nutr; 2009 Jan; 19(1):50-6. PubMed ID: 19121771
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of fibroblast growth factor 23 in phosphate homeostasis and pathogenesis of disordered mineral metabolism in chronic kidney disease.
    Stubbs J; Liu S; Quarles LD
    Semin Dial; 2007; 20(4):302-8. PubMed ID: 17635819
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 1alpha,25-Dihydroxyvitamin D3 upregulates FGF23 gene expression in bone: the final link in a renal-gastrointestinal-skeletal axis that controls phosphate transport.
    Kolek OI; Hines ER; Jones MD; LeSueur LK; Lipko MA; Kiela PR; Collins JF; Haussler MR; Ghishan FK
    Am J Physiol Gastrointest Liver Physiol; 2005 Dec; 289(6):G1036-42. PubMed ID: 16020653
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Physiological regulation and disorders of phosphate metabolism--pivotal role of fibroblast growth factor 23.
    Fukumoto S
    Intern Med; 2008; 47(5):337-43. PubMed ID: 18310961
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hypophosphatemia induced by intravenous administration of saccharated ferric oxide: another form of FGF23-related hypophosphatemia.
    Shimizu Y; Tada Y; Yamauchi M; Okamoto T; Suzuki H; Ito N; Fukumoto S; Sugimoto T; Fujita T
    Bone; 2009 Oct; 45(4):814-6. PubMed ID: 19555782
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bone-kidney axis in systemic phosphate turnover.
    Razzaque MS
    Arch Biochem Biophys; 2014 Nov; 561():154-8. PubMed ID: 24997362
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fibrous dysplasia, phosphate wasting and fibroblast growth factor 23.
    Imel EA; Econs MJ
    Pediatr Endocrinol Rev; 2007 Aug; 4 Suppl 4():434-9. PubMed ID: 17982392
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correlation among hyperphosphatemia, type II sodium phosphate transporter activity, and vitamin D metabolism in Fgf-23 null mice.
    Sitara D
    Ann N Y Acad Sci; 2007 Nov; 1116():485-93. PubMed ID: 17646263
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinical aspect of recent progress in phosphate metabolism. The pathophysiology of diseases caused by aberrant actions of FGF23].
    Shimizu Y; Fukumoto S
    Clin Calcium; 2009 Jun; 19(6):802-7. PubMed ID: 19483274
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Klotho as a regulator of fibroblast growth factor signaling and phosphate/calcium metabolism.
    Kuro-o M
    Curr Opin Nephrol Hypertens; 2006 Jul; 15(4):437-41. PubMed ID: 16775459
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New insights into the role of fibroblast growth factor 23 in chronic kidney disease.
    Nakai K; Komaba H; Fukagawa M
    J Nephrol; 2010; 23(6):619-25. PubMed ID: 20658451
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fibroblast growth factor 23 as a phosphotropic hormone and beyond.
    Fukumoto S; Shimizu Y
    J Bone Miner Metab; 2011 Sep; 29(5):507-14. PubMed ID: 21822586
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fibroblast growth factor 23 and its receptors.
    Yu X; White KE
    Ther Apher Dial; 2005 Aug; 9(4):308-12. PubMed ID: 16076372
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Familial tumoral calcinosis caused by a novel FGF23 mutation: response to induction of tubular renal acidosis with acetazolamide and the non-calcium phosphate binder sevelamer.
    Lammoglia JJ; Mericq V
    Horm Res; 2009; 71(3):178-84. PubMed ID: 19188744
    [TBL] [Abstract][Full Text] [Related]  

  • 19. FGF23 and disorders of phosphate homeostasis.
    Yu X; White KE
    Cytokine Growth Factor Rev; 2005 Apr; 16(2):221-32. PubMed ID: 15863037
    [TBL] [Abstract][Full Text] [Related]  

  • 20. FGF receptors control vitamin D and phosphate homeostasis by mediating renal FGF-23 signaling and regulating FGF-23 expression in bone.
    Wöhrle S; Bonny O; Beluch N; Gaulis S; Stamm C; Scheibler M; Müller M; Kinzel B; Thuery A; Brueggen J; Hynes NE; Sellers WR; Hofmann F; Graus-Porta D
    J Bone Miner Res; 2011 Oct; 26(10):2486-97. PubMed ID: 21812026
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.